Aggrastat tirofiban: Phase IV data; Marketed

In 4,812 patients with coronary artery disease or unstable angina undergoing angioplasty or stenting procedures,

Read the full 152 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE